Values and limitations of serum aminotransferases in clinical trials of nonalcoholic steatohepatitis

Abstract

Serum aminotransferase changes could be useful as surrogates in screening therapies for NASH in clinical trials with appropriate consideration of baseline aminotransferase and histology.